Instituto de Moléstias Cardiovasculares Tatuí

Tatuí 18270-170

0 studies enrolling now · 3 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Heart Failure With Preserved Ejection Fraction

Studies at this site

• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Completed